Case-Based Roundtable
General Dermatology
Eczema
Chronic Hand Eczema
Chronic Spontaneous Urticaria
Alopecia
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Melasma
NP and PA
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management
Prurigo Nodularis
Buy-and-Bill

Article

October 3, 2008

Anika Therapeutics announces Canadian distribution agreement for Elevess

Bedford, Mass. - Anika Therapeutics has signed an agreement with Canderm Pharma, a skincare company in Canada, to distribute and market Elevess throughout Canada, BusinessWire reports.

Bedford, Mass.

- Anika Therapeutics has signed an exclusive agreement with Canderm Pharma, a skincare company in Canada, to distribute and market Elevess throughout Canada, BusinessWire reports.

Elevess is the first hyaluronic acid filler with lidocaine to be approved by the U.S. Food and Drug Administration.

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!